About Northwest Biotherapeutics
Northwest Biotherapeutics is a company based in Bethesda (United States) founded in 1998. It operates as a HealthTech. The company has 25 employees as of December 31, 2024. Northwest Biotherapeutics has completed 2 acquisitions, including Advent BioServices and Flaskworks. Northwest Biotherapeutics offers products and services including DCVax®-L, DCVax®-Direct, and DCVax®-Prostate. Northwest Biotherapeutics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Bethesda, United States
- Employees 25 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Northwest Biotherapeutics, Inc.
-
Annual Revenue
$1.38 M-28.47as on Dec 31, 2024
-
Net Profit
$-83.78 M-33.83as on Dec 31, 2024
-
EBITDA
$-64.46 M-19.88as on Dec 31, 2024
-
Latest Funding Round
$5 M (USD), Post-IPO
Dec 19, 2024
-
Investors
Woodford Investment Management
& 2 more
-
Employee Count
25
as on Dec 31, 2024
-
Investments & Acquisitions
Advent BioServices
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Northwest Biotherapeutics
Northwest Biotherapeutics is a publicly listed company on the OTC with ticker symbol NWBO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Northwest Biotherapeutics
Northwest Biotherapeutics offers a comprehensive portfolio of products and services, including DCVax®-L, DCVax®-Direct, and DCVax®-Prostate. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Personalized vaccine developed for glioblastoma brain cancer treatment.
Vaccine designed for inoperable solid tumor cancer treatment.
Vaccine created for prostate cancer immunotherapy treatment solutions.
Unlock access to complete
Leadership Team
2 people
Software Development Team
2 people
Sales and Marketing
1 people
Manager Team
1 people
Unlock access to complete
Funding Insights of Northwest Biotherapeutics
- Total Funding Total Funding
- Total Rounds 23
- Last Round Post-IPO — $5.0M
-
First Round
First Round
(07 Jul 2010)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Post-IPO - Northwest Biotherapeutics | Valuation |
investors |
|
| Dec, 2021 | Amount | Post-IPO - Northwest Biotherapeutics | Valuation |
investors |
|
| Aug, 2020 | Amount | Post-IPO - Northwest Biotherapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Northwest Biotherapeutics
Northwest Biotherapeutics has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Woodford Investment Management, Yorkville Advisors and Schulze Family Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Offers flexible capital to micro-cap and small-cap firms for growth.
|
Founded Year | Domain | Location | |
|
Diversified investment portfolios are managed for clients by the firm.
|
Founded Year | Domain | Location | |
|
Grants and scholarships are provided by this philanthropic foundation.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Northwest Biotherapeutics
Northwest Biotherapeutics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Advent BioServices and Flaskworks. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provides contract development, GMP manufacturing, and ultra-cold storage for cell therapy.
|
2016 | ||||
|
Manufacturer of immunotherapeutics for research purpose
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Northwest Biotherapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Northwest Biotherapeutics Comparisons
Competitors of Northwest Biotherapeutics
Northwest Biotherapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Northwest Biotherapeutics
Frequently Asked Questions about Northwest Biotherapeutics
When was Northwest Biotherapeutics founded?
Northwest Biotherapeutics was founded in 1998 and raised its 1st funding round 12 years after it was founded.
Where is Northwest Biotherapeutics located?
Northwest Biotherapeutics is headquartered in Bethesda, United States. It is registered at Bethesda, Maryland, United States.
How many employees does Northwest Biotherapeutics have?
As of Dec 31, 2024, the latest employee count at Northwest Biotherapeutics is 25.
What is the annual revenue of Northwest Biotherapeutics?
Annual revenue of Northwest Biotherapeutics is $1.38M as on Dec 31, 2024.
What does Northwest Biotherapeutics do?
Northwest Biotherapeutics, Inc. is engaged in the development of personalized cancer vaccines aimed at treating a wide range of solid tumor cancers. The companys proprietary DCVax platform technology utilizes activated dendritic cells to create tailored immunotherapies. Products such as DCVax-L for glioblastoma, DCVax-Direct for inoperable tumors, and DCVax-Prostate for prostate cancer are developed through clinical trials. The focus is placed on advancing cancer treatment solutions within the healthcare and biotechnology sectors.
Who are the top competitors of Northwest Biotherapeutics?
Northwest Biotherapeutics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Northwest Biotherapeutics offer?
Northwest Biotherapeutics offers DCVax®-L, DCVax®-Direct, and DCVax®-Prostate.
Is Northwest Biotherapeutics publicly traded?
Yes, Northwest Biotherapeutics is publicly traded on OTC under the ticker symbol NWBO.
How many acquisitions has Northwest Biotherapeutics made?
Northwest Biotherapeutics has made 2 acquisitions, including Advent BioServices, and Flaskworks.
Who are Northwest Biotherapeutics's investors?
Northwest Biotherapeutics has 3 investors. Key investors include Woodford Investment Management, Yorkville Advisors, and Schulze Family Foundation.
What is Northwest Biotherapeutics's ticker symbol?
The ticker symbol of Northwest Biotherapeutics is NWBO on OTC.